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Primary cultures of rat hepatocytes were used to investigate whether and how eight isothiocynates (ITCs)
with different chemical structures (the aromatic benzyl, 4-hydroxybenzyl, phenethyl isothiocyanates and
the aliphatic allyl, napin, iberin, raphasatin isothiocyanates and sulforaphane) derived from hydrolyzed
glucosinolates, were able to modulate cytochrome P450 (CYP) and antioxidant/detoxifying enzymes
and to activate the Nrf2 transcription factor. The aromatic ITCs at 40 lM markedly increased the tran-
scription of CYP1A1 and 1A2 mRNA and increased the associated ethoxyresorufin O-deethylase (EROD)
activity after 24 h of treatment. By contrast, the aliphatic ITCs (40 lM) decreased CYP1A1 and 1A2 tran-
scription, together with the corresponding EROD activity. The same treatment also caused a striking and
similar transcriptional repression of CYP3A2, and the corresponding benzyloxyquinoline debenzylase
activity in response to all the ITCs tested. In the same culture conditions, most of the antioxidant/detox-
ifying enzymes were significantly up-regulated by 40 lM ITCs. In particular, NAD(P)H:quinone oxidore-
ductase and heme oxygenase-1 were induced, although to different levels, at transcriptional, protein and/
or activity levels by all the ITCs. However, glutathione S-transferase activity was not induced by the allyl,
benzyl, and 4-hydroxybenzyl ITCs, glutathione reductase activity was not induced by benzyl, and
4-hydroxybenzyl ITCs and catalase activity was not induced by allyl ITC. As for the Nrf2 transcription fac-
tor, a partial translocation of its protein from the cytosol to the nucleus was revealed by immunoblotting
after 1 h of treatment for all the ITCs tested. The ability of ITCs to induce the antioxidant and phase II
enzymes did not appear to be affected by their hydrophilicity or other structural factors. Taken together,
these results show that these ITCs are effective inducers of ARE/Nrf2-regulated antioxidant/detoxifying
genes and have the potential to inhibit, at least in rat liver, the bioactivation of carcinogens dependent
on CYP3A2 catalysis.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
A variety of studies have consistently shown that phytochemi-
cals present in foods and food products play a protective role in
the etiology of various diseases (Xiang et al., 2009). Over the past
20 years, glucosinolates (GLs) and their hydrolysis products, iso-
thiocyanates, have received much attention by scientists thanks
to their anticancer and antioxidant properties (Lam et al., 2009;
Nakamura and Miyoshi, 2010). ITCs are abundant in cruciferous
vegetables such as broccoli, watercress, Brussels sprouts, cabbage
and cauliflower. Over 120 different GLs have been identified, and
they have been classified into three main groups: (1) the aliphatic
group characterized by an alkyl or alkenyl side-chain (e.g. sinigrin),
(2) the aromatic group (e.g. gluconasturtin) and (3) the indolylll rights reserved.
: +39 0503153328.
go@ibba.cnr.it (V. Longo).group (e.g. glucobrassicin) (Xiang et al., 2009). GLs are normally
found in the cytoplasm of plant tissues where they have little bio-
activity. When the tissue is ruptured by chewing, preparation for
cooking, heating or insect attack, the glucosinolates are released
and can interact with myrosinase, an enzyme present in the plant
cell wall, and hydrolysis products are formed. At neutral pH, the
GLs are mainly hydrolyzed to stable ITCs and, in small amounts,
to other compounds such as nitriles and thiocyanates (Zhang and
Talalay, 1994). Most of the dietary isothiocyanates absorbed by
mammals from ingested plant material are formed by the action
of myrosinase from gastrointestinal tract bacteria.
It is slowly emerging that the mechanisms underlying the can-
cer chemopreventive effects of ITCs are multiple (Conaway et al.,
2002; Juge et al., 2007; Cheung and Kong, 2010; Zhang, 2010)
and include the induction of apoptotic pathways, the inhibition
of angiogenesis, their anti-inflammatory properties, and the mod-
ulation of phase I and phase II biotransformation enzymes. These
Table 1
Glucosinolates, isothiocyanates and chemical structures used for the experiments.
Glucosinolates Isothiocvanates (ITCs)
R-N@C@S
–R groups
Glucoraphanin Sulforaphane (SFN) CH3S(O)CH2CH2CH2CH2
Glucoiberin Ibcrin isothiocyanate (IBITC) CH3S(O)CH2CH2CH2
Glucoraphasatin Raphasatin isothiocyanate
(RITC)
CH3SCH@CHCH2CH2
Gluconapin Napin isothiocyanate (NITC) CH2@CHCH2CH2
Sinigrin Allyl isothiocyanate (AITC) CHj@CHCH2
Gluconasturtin Phenethyl isothiocyanate
(PEITC)
Glucotropeolin Benzyl isothiocyanate (BITC)
Glucosinalbin 4-Hydroxybenzyl
isothiocyanate (IBITC)
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reactions (phase I) and conjugation reactions (phase II). The ability
of ITCs to modulate the biotransformation enzymes is thought to
be connected to their ability to inhibit the catalytic activity of a
number of cytochrome P450 (CYP) enzymes, which activate certain
carcinogens, and is also thought to be connected to their ability to
induce the expression of some antioxidant and phase II enzymes
(Hayes et al., 2008).
ITCs such as phenylethyl isothiocyanate (PEITC) and other aro-
matic isothiocyanates, when administered to mice or rats, inhibit
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumor
formation as well as some cytochrome P450s (CYP) including
CYP1A1, 1A2, 2B1 and 2E1 (Yang et al., 1994). In vitro experiments
using rat liver microsomes have demonstrated that aromatic ITCs
are strong inhibitors of EROD and PROD (dependent on 1A1/2
and 2B1, respectively), but the alkyl ITCs such as sulforaphane
(SFN) and allyl isothiocyanate (AITC) are weak inhibitors of these
CYP isoforms (Conaway et al., 1996).
Goosen et al. (2001) have also described a mechanism-based
inhibition of CYP1A1, 1A2, 2B1 and 2E1 but not 2C9, 2D6 and
3A2 by benzyl isothiocyanate (BITC) in rat liver microsomes. How-
ever, the administration of ITCs to rodents may provoke either an
increase or decrease of specific CYP activity and tumorogenesis,
depending on which ITC is used and on the treatment regimen
(Zhang and Talalay, 1994). For example, the chronic administration
of PEITC was found to increase the levels of both CYP2B1 and 2E1
as well as the carcinogenic toxicity (Smith et al., 1993).
From the previous example, it is clear that the results of CYP
inhibition obtained in vitro with microsomes or recombinant en-
zymes might differ to those obtained in vivo. It is possible that
the use of living cells (hepatocytes or liver slices) might better re-
flect what occurs in vivo. However, few studies have used primary
hepatocytes to evaluate the effects of ITCs on phase I and II en-
zymes. Studies conducted in primary rat hepatocytes show the po-
tential of the aliphatic SFN to markedly inhibit EROD and PROD
activity (markers of CYP1A1/1A2 and 2B1, respectively) (Mahèo
et al., 1997), whereas different effects were obtained with rat liver
slices treated with the aliphatic SFN and erucin (Hanlon et al.,
2008). In human hepatocytes, SFN greatly decreased the expres-
sion of the CYP1A1, 1A2 and CYP3A4 genes, whereas the aryl PEITC
strongly induced the expression of the CYP1A1 and 1A2 genes
(Gross-Steinmeyer et al., 2010).
As far as phase II is concerned, it was proposed that ITCs operate
by activating the nuclear factor E2-related protein (Nrf2) (Fahey
et al., 1997). Nrf2 is a basic-leucine zipper transcription factor
which, under basal conditions, is present in an inactive form in
the cytoplasm, bound to the Kelch-like ECH-associated protein 1
(Keap1) (Itoh et al., 1999). Various agents, such as ROS or weak
electrophiles (e.g. ITCs), can alter the Keap1-Nrf2 protein complex
and liberate Nrf2 by phosphorilating or alkylating one or more of
the 27 cysteine residues of Keap1. Nrf2 is then free to migrate into
the nucleus. Once free from Keap1, Nrf2 dimerizes with small Maf
protein and binds to antioxidant responsive element (ARE) sites in
the promoter of antioxidant and phase II genes, thereby inducing
the transcription of these genes.
Many authors have studied the ability of a wide range of ITCs to
induce the ARE/Nrf2 regulated enzymes. In particular, a great deal
of attention has been to the NAD(P)H:quinone oxidoreductase
(NQO1) – known as the most sensitive ARE/Nrf2 responsive en-
zyme. It has been studied in various hepatoma cell lines (Postner
et al., 1994; Tawfiq et al., 1995; Ye and Zhang, 2001;Vermeulen
et al., 2006). Some authors have also verified what causes the acti-
vation of Nrf2 signaling pathway (Jeong et al., 2005; Keum et al.,
2008; Prawn et al., 2008). However, studies of ITCs in rat and hu-
man hepatocytes or liver slices are limited to SNF, PEITC and erucin
and only the induction of NQO1 and other enzymes were evaluatedbut not the activation of Nrf2 (Mahèo et al., 1997; Payen et al.,
2001; Hanlon et al., 2009; Gross-Steinmeyer et al., 2010).
The main aim of our work was to investigate whether various
GL hydrolysis-derived ITCs, with specific chemical structures, were
differently able to modulate phase I and phase II enzymes at cata-
lytic and/or transcriptional levels. For this, we used sandwich cul-
tures of primary rat hepatocytes, a unique in vitro system that
maintains specific hepatic cytomorphology as well as the function
of their drug metabolism, deposition and toxicity, closely resem-
bling the in vivo setting (Swift et al., 2010). GL hydrolysis-derived
aromatic ITCs (benzyl, 4-hydroxybenzyl and phenethyl isothiocya-
nates), alkenyl aliphatic ITCs (allyl and napin isothiocyanates) and
aliphatic ITCs with an additional sulfur atom (iberin, raphasatin
and sulforaphane isothiocyanates), were assayed (Table 1). Instead
of synthetic or pure ITCs we chose to study different GL hydrolysis
products in order to better simulate in vivo conditions, where the
biotransformation of glucosinolates to isothiocyanates occurs in
the intestine by microbial myrosinase.2. Materials and methods
2.1. Chemicals
Collagenase; dexamethasone; insulin; glucagon; penicillin/streptomycin; ampi-
cillin/kanamycin; fetal bovine serum; HEPES; Tween 20; PMSF; leupeptin; apopro-
tein; pepstatin; Williams E medium; BSA; EGF; NADPH; EDTA; EGTA; GSH; GSSG;
and H2O2 were all supplied by Sigma–Aldrich (St. Louis, MO). Rabbit polyclonal
anti-Nrf2 (sc-13032) and anti-heme oxygenase-1 (sc-10789) were from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA). Collagen (type I) was prepared by the method
of Beken et al. (1998).
2.2. Preparation of glucosinolates
The glucosinolates were isolated from different plant sources using an im-
proved purification method (Visentin et al., 1992) and the purity of GLs as deter-
mined by HPLC and NMR spectrometry, was in the range of 95–99% (Razis et al.,
2010).
2.3. Primary rat hepatocytes isolation, culture and treatments
Hepatocytes were isolated from 200 to 300 g Wistar male rats with free access
to drinking water and food and on a 12 h light/dark cycle. Rats were anesthetized
with 40 mg/kg ketamine (Zoletil

) and the liver was perfused as described previ-
ously (De Smet et al., 1998). After filtration and centrifugation, the cell viability
was determined by trypan blue exclusion. The cells were dispersed in Williams E
medium containing 39 ng/ml dexamethasone, 0.5 U/ml insulin, 0.007 lg/ml gluca-
gon, 5 lg/ml penicillin and streptomycin, 5 lg/ml ampicillin and kanamycin and
10% fetal bovine serum. The cells were plated at a density of 4.5  106 cells/8 ml
on 100 mm cell culture dish pre-coated with 3 ml of collagen (type I) solution
(1 mg/ml). The cultures were maintained at 37 C in 5% CO2 in a humidifier incuba-
tor. After 5 h, the medium was replaced with serum-free Williams E medium sup-
plemented with 2% BSA, 7.5 lg/ml hydrocortisone 21-hemisuccinate sodium salt
Table 2
Primer pairs, annealing temperature and product size for RT-PCR experiments.
Gene Forward (50–30) Reverse (50–30) Annealing T. (C) Product size (bp)
NQO1 ACTCGGAGAACTTTCAGTACC TTGGAGCAAAGTAGACTGGT 59 492
HO-1 CAGGGTGACAGAAGAGGCTAAGAC TGAGGACCCATCGCAGGAG 66 229
CYP1A1 GCTTCACACTTATCGCTAATGG TGTTGGGTCTGAGGCTATGG 58 125
CYP1A2 CACAGCACAACGAGGGACAC CCAAGCCGAAGAGCATCACC 58 199
CYP3A2 AGGATGACTGCCAGGAGGAC AGAGGGAGAACACCGAGGAG 58 100
b-actin CCCCATTGAACACGGATT CATCTTTTCACGGTTGGCCTTA 67 150
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24 h. After this period, the medium was removed and a second layer of type I col-
lagen was added to create a collagen-gel sandwich culture (Beken et al., 1998) and
after 45 min serum-free Williams E medium was added again. The cells were main-
tained for additional 24 h before treatments. Glucosinolates (glucoiberin, sinigrin,
glucosinalbin, gluconapin, glucotropeolin, glucoraphasatin, gluconasturtin and
glucoraphanin) were incubated at 37 C for 15 min at pH 7.0 with myrosinase to
permit a complete hydrolysis that originates stable ITCs (hereafter named ITC solu-
tions) as the only GLs hydrolysis product (Leoni et al., 2000). Cell experiments were
performed with different concentrations (20–60 lM) of isothiocyanate solutions for
1, 4, 24 h. At 20–40 lM concentrations, unlike 60 lM, ITCs solutions produced no
adverse cytotoxic effects over the exposure periods compared with the vehicle-only
controls, as measured by lactate dehydrogenase assay.2.4. Enzymatic activities
After 24 h the end of treatment, the medium was removed and a collagenase
solution was added. After 30 min, recovered cells were centrifuged (400g) for
3 min at 4 C. The cell pellet was sonicated and used for the microsomal preparation
(Jagow et al., 1965). Total protein concentration was determined by the method of
Lowry et al. (1951). NAD(P)H:quinone oxidoreductase (NQO1) activity was
measured by the method of Bensen et al. (1980). Glutathione-S-transferase (GST)
activity was quantified as previously described by Habig et al. (1974), using
1-chloro-2,4-dinitrobenzene as substrate. The GSSG reductase activity was
measured monitoring the consumption of NADPH for 1 min at 340 nm while the
catalase activity was monitored following the H2O2 decomposition at 240 nm, as
described by Cao and Li (2002). Heme oxygenase-1 (HO-1) activity was determined
by the method of Naughton et al. (2002). Lactate dehydrogenase activity was
assayed as previously described (Deker and Lohmann-Matthes, 1988).
In general, the cytochrome P450-dependent enzymatic assays with the hepato-
cyte microsomes were carried out at 37 C for 30 min in a 1 ml reaction mixture as
previously reported (Amato et al., 1996). The dealkylation activities of ethoxyres-
orufin-O-deethylase (EROD), ethoxycoumarin-O-deethylase (ECOD), and benzyl-
oxyquinoline debenzylase (BQD) were measured by monitoring fluorimetrically
the formation of the corresponding hydroxyl products as previously reported
(Burke and Mayer, 1974; Aitio, 1978; Stresser et al., 2000).2.5. RNA extraction and cDNA synthesis
Total cellular RNA was extracted from primary rat hepatocytes 4 h after ITC
treatment, using the RNeasy Mini Kit (Qiagen, Valencia, CA), following the supplied
protocol. RNA was quantified using NanoDrop (Celbio, MI, Italy); its purity and
integrity were evaluated by checking the absorbance ratio at 260–280 nm and
assessing the sharpness of 18S and 28S ribosomal RNA bands on agarose gel stained
with ethidium bromide. Genomic DNA elimination and reverse transcription of to-
tal RNA were performed using QuantiTect Reverse Transcription Kit (Qiagen).2.6. RT-PCR
Two microliters of cDNA were added to a PCR Master Mix (GoTaq Green Master
Mix, Promega, Madison, WI) for the amplification reaction (various cycles)
performed using for each transcript 400 nM of forward–reverse primers for heme
oxygenase-1 (GenBank Accession No. NM_012580.2), NQO1 (GenBank Accession
No. NM_017000.3), CYP1A1 (GenBank Accession No. NM_012540.2), CYP1A2
(GenBank Accession No. NM_012541.3), CYP3A2 (GenBank Accession No.
NM_153312.2), b-actin, as housekeeping gene, (GenBank Accession No.
NM_031144.2) and the annealing temperature indicated in Table 2. The b-actin con-
trols originate from the same lane of the agarose gel of samples. The DNA fragments
were separated on ethidiumbromide-stained 1% agarose gel and visualized by trans-
illumination with ultraviolet light. Bands obtained from five independent rat exper-
iments were quantified by an Image J software. The results have been normalized to
b-actin levels and are expressed as percentages of control. Results are reported as
means ± SD of cells from five independent experiments using five rats.2.7. Preparation of nuclear fractions
Nuclear and cytosolic extracts were prepared by previously established meth-
ods (Balogun et al., 2003). Briefly, hepatocytes were washed twice with 1 PBS.
Cells were then harvested in 1 ml of PBS and centrifuged at 800g for 3 min at
4 C. The pellet was carefully resuspended in 200 ll of cold hypotonic buffer, con-
sisting of 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 lM
dithiothreitol and complete protease inhibitor cocktail (Sigma antiprotease cocktail
P8340). After addition of NP40 to a final concentration of 0.3%, the cells were vor-
texed and centrifuged at 800g for 3 min at 4 C. The resulting nuclear pellet was
resuspended in 30 ll of cold nuclear extraction buffer (20 mM HEPES (pH 7.9),
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 lM dithiothreitol, 25% glycerol and protease
inhibitors) and incubated on ice for 30 min. The nuclear extract was finally centri-
fuged at 15000g for 15 min at 4 C. The supernatant containing nuclei proteins was
aliquoted and stored at 30 C.
2.8. Immunoblot analysis
Nuclear and microsomal proteins from primary rat hepatocytes were separated
according to Laemmli (1970) on SDS-10% (v/v) 1.0 mm thick polyacrylamide gels
and then electrophoretically transferred onto nitrocellulose membranes following
the method of Towbin et al. (1979). Antibodies used were anti-Nrf2 (1: 1000,
sc13032, Santa Cruz Biotechnology, Heidelberg, Germany), anti heme oxygenase-
1 (1:1000, sc-10789, Santa Cruz Biotechnology, Heidelberg, Germany), b-actin
(1:1000, sc-130657, Santa Cruz Biotecnology, Heidelberg, Germany) and goat
anti-rabbit (1:2000 or 1:5000). Immunoreactive proteins were visualized with a
chemiluminescence reaction Kit (EuroClone, MI, Italy) and bands obtained from five
independent rat experiments were electronically scanned and quantified by an
Image J software.
2.9. Statistical analysis
Results are reported as means ± SD. Statistical significance was determined by
Student’s t-test for comparison between control and treated groups. p Value < 0.05
was considered to be significant.
3. Results
3.1. The effect of ITC solutions on cytochrome P450
To study the modulation of some CYPs, cells were treated for
24 h with various solutions, each containing one of the following
isothiocyanates: AITC, NITC, PEITC, RITC, HBITC, BITC, IBITC, SFN
produced by the hydrolysis of 20–40 lM GLs. The following mono-
oxygenase activities were evaluated: ethoxyresorufin-O-deethy-
lase (EROD), marker of CYP1A1/1A2 (Burke and Mayer, 1974),
ethoxycoumarin-O-deethylase (ECOD), marker of many CYPs, the
most noteworthy being CYP1A1/2, 2A, 2B, 2C and 2E1 (Funae and
Imaoka, 1993), and benzyloxyquinoline debenzylase (BQD), mar-
ker of CYP3As (Stresser et al., 2000). In Fig. 1A–C, only the most
effective results, obtained with the 40 lM treatments, are de-
picted. Using 20 lM ITCs, similar enzymatic profiles with lower
values were observed (data not shown). As illustrated in Fig. 1A,
EROD activity, selective for the CYP1A1/1A2, was significantly
inhibited only by the aliphatic ITCs SFN and IBITC. Conversely,
the aromatic PEITC, HBITC and BITC increased EROD activity to
178%, 225%, 233% of the control level, respectively. Also ECOD
activity, responsive to the catalysis of CYP1A1/1A2, was signifi-
cantly induced by the same aromatic ITCs, but its inhibition by
the aliphatic ITCs was not observed. Surprisingly, BQD activity
Fig. 1. Effect of 40 lM ITC solutions on the dealkylation activities of ethoxyresorufin (EROD) (A), ethoxycoumarin (ECOD) (B) and benzyloxyquinoline (BQD) (C). Activities
were measured in microsomes from 24 h treated hepatocytes. Results are expressed as percentages of EROD, ECOD and BQD control activities (1.6 ± 0.7 pmol/min/mg prot.,
21 ± 11.6 pmol/min/mg prot., 55.6 ± 0.5 pmol/min/mg prot., respectively). Mean ± SE of cells from five rats. ⁄Significantly different from controls by Student’s t-test, p < 0.05.
⁄⁄p < 0.01. ⁄⁄⁄p < 0.001.
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anates tested.
To examine the effect of ITC solutions on CYPs at the transcrip-
tional level, semi-quantitative RT-PCR was performed using theFig. 2. A representative RT-PCR analysis of CYP1A1, CYP1A2 genes and b-actin houseke
housekeeping gene, in primary rat hepatocytes of control (CTR) and treated with 20 and 4
by electrophoresis on agarose gels and stained with ethidium bromide. Quantitative
normalized to b-actin levels and are expressed as percentages of control. Mean ± SE of ce
controls by Student’s t-test, p < 0.001.primer pairs shown in Table 2. PCR analysis with a different num-
bers of amplification cycles allowed us to compare the levels of
CYP1A1, CYP1A2 and CYP3A2 mRNA in rat hepatocytes treated
for 4 h with two different concentrations (20 and 40 lM) of ITCseping gene performed with 28, 30, 32 cycles for CYPs and 24, 26 and 28 cycles for
0 lM aromatic ITC solutions (PEITC, HBITC and BITC). PCR products were separated
representation of the RT-PCR analysis is reported below. The results have been
lls from five independent experiments using five rats. ⁄⁄⁄Significantly different from
Fig. 3. A representative RT-PCR analysis of CYP3A2 genes and b-actin housekeeping gene performed with 30, 32, 34 cycles for CYP and 24, 26 and 28 cycles for housekeeping
gene, in primary rat hepatocytes of control (CTR) and treated with all tested 20 and 40 lM ITC solutions. PCR products were separated by electrophoresis on agarose gels and
stained with ethidium bromide. Quantitative representation of the RT-PCR analysis performed is reported below. The results have been normalized to b-actin levels and are
expressed as percentages of control. Mean ± SE of cells from five independent experiments using five rats. ⁄⁄⁄Significantly different from controls by Student’s t-test, p < 0.001.
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ings, only treatment with the aromatic ITCs (PEITC, HBITC, BITC) in-
creased both CYP1A1 and CYP1A2 transcripts (Fig. 2). Treatment
with AITC, NITC, RITC, IBITC, SFN did not affect CYP1A1 or CYP1A2
expression (data not shown).
In Fig. 3, CYP3A2mRNA expression is shown. CYP3A2, belonging
to the CYP3A subfamily, is highly expressed in the untreated rat liver
(Mahnke et al., 1997). Its expression markedly decreased compared
to the control level by all the ITCs in a dose dependent manner.3.2. Effect of ITC solutions on antioxidant and phase II enzyme activity
In the microsomes or cytosol of control hepatocytes and hepa-
tocytes treated for 24 h with 40 lM ITC solutions, the activity of
NQO1, HO-1, GSSG reductase, GST, which is regulated by Nrf2 (Juge
et al., 2007) and catalase, was determined (Fig. 4A–E).
As expected, in primary rat hepatocytes all the tested com-
pounds induced by about 2- to 3.5-fold NQO1 activity, which was
the most sensitive enzyme (Fig. 4A). The greatest enhancements
in NQO1 activity of about 3- to 3.5-fold with respect to the control
value (52 ± 7.2 nmol/min/mg prot), were observed after treatmentFig. 4. Effect of 40 lM ITCs solutions on activity of antioxidant and phase II drug-met
glutathione-S-transferase (C); glutathione reductase (D) and catalase (E). Activities were m
Results are expressed as percentages of control values. Mean ± SE of cells from five
⁄⁄⁄p < 0.001.with the aromatic PEITC and the aliphatic NITC and RITC, whereas
the lowest enhancements were observed in response to the aro-
matic HBITC and aliphatic AITC treatments, proving that there is
no evident relationship between ITCs structure and activity. HO-1
activity (Fig. 4B) was significantly induced by similar amounts
(about 1.5- to 2-fold of control value: 17.5 ± 6.1 pmol/min/mg prot)
by all the ITCs solutions. GST activity was significantly induced
(about 1.3–1.5 of control value: 256 ± 9.3 nmol/min/mg prot) by
the NITC, PEITC, RITC, IBITC and SFN but not by the aliphatic AITC
and the aromatic HBITC and BITC (Fig. 4C). We observed a weak
though significant increase in glutathione reductase activity (about
1.3- to 1.5-fold of control value: 113 ± 8.1 nmol/min/mg prot)
(Fig. 4D), only following treatment with AITC, NITC, PEITC, BITC,
IBITC and SFN. RITC and HBITC failed to induce glutathione reduc-
tase activity. As for catalase (Fig. 4E), all the ITCs but AITC were able
to induce its activity (about 1.5- to 2.5-fold of the control value:
167 ± 6.1 nmol/min/mg prot).
The NQO1 and HO-1 enzymes were chosen for additional anal-
ysis at the transcriptional level to further investigate their respon-
siveness to ITC treatments. The expression of their transcripts were
analyzed by RT-PCR in primary rat hepatocytes, using the sets ofabolizing enzymes: NAD(P)H:quinone oxidoreductase (A); heme oxygenase-1 (B);
easured in microsomes or cytosol of control cells (CTR) from 24 h ITCs treated cells.
rats. ⁄Significantly different from controls by Student’s t-test, p < 0.05. ⁄⁄p < 0.01.
Fig. 5. A representative RT-PCR analysis of NAD(P)H:quinone oxidoreductase (NQO1), heme oxygenase-1 (HO-1) genes performed with 25, 27 and 29 cycles in primary rat
hepatocytes of control (CTR) and treated 20 and 40 lM with ITC solutions. PCR products were separated by electrophoresis on agarose gels and stained with ethidium
bromide. Quantitative representation of the RT-PCR analysis is reported below. The results have been normalized to b-actin levels and are expressed as percentages of control.
Mean ± SE of cells from five independent experiments using five rats. ⁄⁄⁄Significantly different from controls by Student’s t-test, p < 0.001.
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tions (20 and 40 lM) of ITC solutions for 4 h. As shown in Fig. 5,
all the ITC treatments increased the expression of NQO1 and HO-
1 genes with the respect to the control levels, although to different
extents.
The effect of ITCs solutions on heme oxygenase-1 was also as-
sessed at the protein level by Western blot analysis. In Fig. 6 it is
shown a representative immunoblot detected by chemiolumines-
cence with 5 min exposure using microsomes of five independent
experiments. In microsomes from all hepatocytes treated with
40 lM ITCs, the anti-rat HO-1 antibodies revealed a significantFig. 6. Western blot analysis of heme oxygenase-1 protein in microsomes (50 lg) of c
samples were subjected to SDS–PAGE, electrophoretically transferred to a nitrocellul
Densitometric analysis of the Western blot data are shown on the right side. The results
Mean ± SE of cells from five independent experiments using five rats. ⁄⁄Significantly diffincrease in intensity of a immunoreactive protein band of about
1.5- to 2.5-fold with respect to the control, in agreement with re-
sults from the enzymatic activity assays.
3.3. Effect of ITC solutions on Nrf2
To verify whether the Nrf2 pathway was activated in primary
rat hepatocytes treated for 1 h with 40 lM ITC solutions, we ana-
lyzed by Western blot cytosolic and nuclear fractions prepared
from control and ITCs treated-cells (Fig. 7). A strong protein band
in control cytosols was revealed by an anti-rat Nrf2 antibody,ontrol (CTR) cells and cells treated for 24 h with 40 lM ITC solutions. Microsomal
ose membrane, and probed with polyclonal antibodies raised against rat HO-1.
have been normalized to b-actin levels and are expressed as percentages of control.
erent from controls by Student’s t-test, p < 0.01. ⁄⁄⁄p < 0.001.
Fig. 7. Western blotting analysis of Nrf2 in nuclear and cytosolic extracts of control cells (CTR) and cells treated with 40 lM ITCs solutions. Protein samples (30 lg) were
subjected to SDS–PAGE, electrophoretically transferred to a nitrocellulose membrane, and probed with polyclonal antibodies raised against rat Nrf2. Densitometric analysis of
the Western blot data are shown on the right side. The results have been normalized to b-actin levels and are expressed as percentages of control. Mean ± SE of cells from five
independent experiments using five rats. ⁄⁄⁄Significantly different from controls by Student’s t-test, p < 0.001.
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cells (data not shown). This protein band was faint or not visible
in the control nuclei but was induced (to different levels depending
on the particular ITC used), in the nuclear extracts of all the ITCs
treated hepatocytes.
4. Discussion
In the present study, we investigated whether eight ITCs with
different chemical structures (the aromatic PEITC, BITC, HBITC, the
aliphatic AITC, NITC and the aliphatic with an additional sulfur
atom, SFN, IBITC, RITC) were able tomodulate CYP isoforms, antiox-
idant enzymes and phase II enzymes, or activate Nrf2 at the tran-
scriptional and/or catalytic and protein levels in primary rat
hepatocytes. Liver parenchymal cells are a widely accepted in vitro
model to evaluate mechanisms of drug metabolism. Primary hepa-
tocytes have the necessary intracellular machinery and physiologi-
cal concentrations of cofactors for both phase I and phase II
reactions, aswell as the complete array of hepatic transport proteins
and nuclear receptors, which allow for proper regulation and induc-
tion of enzymes and transport proteins (Swift et al., 2010).
First, we examined the cytotoxic effect of the ITC solutions up to
60 lM in primary rat hepatocytes. The aromatic ITCs proved cyto-
toxic at the highest concentration used, as assessed by the lactate
dehydrogenase activity. The toxic effects of the ITC solutions were
compared to the same solutions at a lower concentrations (20 and
40 lM) that are not toxic and are similar to those described when
pure SFN was tested in primary rat hepatocytes (Payen et al., 2001)
and when other ITCs were assayed in Hepa-1c1c cells (Tawfiq et al.,
1995). Thus, in our culture conditions, the ITC solutions did not
cause any particular over toxicity. When assayed in the hepatic
cells at 40 lM for 24 h, only the aliphatic SFN and IBITC caused a
significant inhibition of the microsomal EROD activity (a selective
marker for CYP1A1 and 1A2) but not ECOD activity (a marker for
many CYPs including CYP1A1 and 1A2). By contrast, the treatmentwith the aromatic ITCs (PEITC, BITC and HBITC) significantly in-
creased both EROD and ECOD activity and the expression level of
CYP1A1 and CYP1A2 mRNA.
This observed regulation pattern toward EROD is very different
to that obtained with the direct incubation of rat liver microsomes
with ITCs. Conaway et al. (1996) found that the aromatic BITC and
PEITC had a greater inhibitory affect on EROD than that produced
by the aliphatic AITC and SFN. However, in experiments with rat
and human hepatocytes SFN reduced CYP1A1/1A2-dependent
EROD activity, whereas the aromatic PEITC induced the expression
of the CYP1A1 and 1A2 genes, in agreement with our results
(Mahèo et al., 1997; Gross-Steinmeyer et al., 2010).
The observed induction of EROD activity and CYP 1A1 and 1A2
transcripts by the aromatic BITC, HBITC and PEITC was likely med-
iated by AhR, a transcriptional factor known to be activated by aro-
matic planar ligands and in particular by polycyclic aromatic
hydrocarbons (Denison and Nagy, 2003). In hepatocyte cultures,
the transcriptional increase of CYP1A1 and 1A2 genes may over-
whelm the original mechanism-based inhibition by the aromatic
ITCs of corresponding microsomal enzymes.
On the other hand, the observed inhibition of EROD by SFN and
IBITC, may be explained by the fact that both compounds are
rather hydrophilic [log p = 0.15–0.17 (Vermeulen et al., 2009)]
compared to the other ITCs used (log p = 1.9–3.2) and might have
produced higher cellular accumulation levels as suggested by a
study on the SFN, AITC, BITC and PEITC in HepG2/EpRE-TR-GFP
cells (Ye and Zhang, 2001). It should be noted that a portion of ITCs
are present in the cells as thiol conjugates which have their own
formation and deconjugation kinetics and have less inhibition
power than that of the parent ITCs (Conaway et al., 2002).
Unexpectedly, our results revealed a strong inhibition of micro-
somal BQD activity, a marker of CYP3As, in response to all the ITC
solutions without any clear relation to chemical structure, con-
trasting therefore with results obtained by Hanlon et al. (2008)
in rat liver slices, where SFN treatment up to 50 lM failed to affect
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that the inhibition of BQD was likely due to a marked decrease of
CYP3A2 gene expression (CYP3A2 is the major CYP gene belonging
to the CYP3A subfamily in rat liver) after 4 h ITC treatment. The
inhibition of a CYP3A (CYP3A4) at the transcriptional level has also
been described in human hepatocytes treated with SFN (Mahèo
et al., 1997; Gross-Steinmeyer et al., 2010). It is interesting to note
that suppression of BQD activity by ITCs might not be occurring at
the protein level through a mechanism-based inhibition consider-
ing that there is evidence that in rat liver microsomes BITC does
not inhibit the CYP3A2 activity (Goosen et al., 2001). Since SFN
has been reported to be an effective antagonist of human PXR
(Zhou et al., 2007), an hepatic transcriptional factor that regulates
the expression of CYP3A genes, our observed reduction in CYP3A2
mRNA might be due to a direct effect of ITCs on rat PXR.
Taking into account that CYP3A4 is involved in the biotransfor-
mation of over 50% of all therapeutic drugs, the inhibition of CY-
P3As by ITCs could have an important influence on drug–drug
interactions, bioactivation of CYP3A-dependent carcinogens and
other PXR-regulated biotransformation pathways. For example
treatment with SFN and PEITC in human hepatocytes was found
to reduce the bioactivation of the hepatocarcinogenic mycotoxin
aflatoxin B1 to the genotoxic form: aflatoxin B1-8,9-oxide, a reac-
tion catalyzed by CYP3A4 (Gross-Steinmeyer et al., 2010).
However, the chemopreventive effects of ITCs may not neces-
sarily involve modulation of CYP-mediated bioactivation of carcin-
ogens. A major protective mechanism of ITCs is the induction of
antioxidant and phase II ARE-driven genes such as NQO1, HO-1
and GST, which are under control of the transcription factor Nrf2.
Most studies screening the cancer chemopreventing properties of
electrophylic compounds including ITCs are based on induction
of NQO1 and other genes in various hepatoma cell lines (Postner
et al., 1994; Ahn et al., 2010).
In general the induction potency of these compounds towards
phase II enzymes was related to their chemical reactivity with
the sulfhydryl groups (Dinkova-Kostova et al., 2002). However,
the degree of induction of these enzymes by ITCs was found to vary
with the cell lines and was thought to be dependent on their over-
all intracellular accumulation levels (Ye and Zhang, 2001).
Our results in primary rat hepatocytes, which are a better model
than hepatoma cell lines for the intact liver may help shed light on
the structure–activity relationship of ITCs on Nrf2/ARE-dependent
gene expression,
In agreement with earlier studies in rat hepatocytes (Mahèo
et al., 1997; Payen et al., 2001), we found that SNF increases the
activity not only of NQO1 and GST but also of other antioxidant/
detoxifying enzymes such as HO-1, GSSG-red and catalase. As
was previously observed in hepatoma cell lines (Jeong et al.,
2005), we have shown that in the rat hepatocytes the induction
of these enzymes also occurred through the activation of Nrf2 pro-
tein and its subsequent translocation into the nucleus (Fig. 7). Our
findings show that all the ITCs tested increased the HO-1 and
NQO1 enzymes at transcriptional and activity levels. On the other
hand, the activities of GST, GSSG-red and catalase were signifi-
cantly increased only by some ITCs. Indeed, AITC, BITC and HBITC
failed to induce the GST activity, whereas BITC and HBITC did not
induce GSSG-red activity, and AITC failed to induce catalase.
The ability of ITCs to induce NQO1 and other enzymes did not
appear to be linked to hydrophilicity or presence of an aromatic
ring, whereas the ability of ITCs to modulate CYPs did seem to de-
pend on ITC structure. The disparity in the enzymatic induction by
ITCs is probably due to their different cellular uptake, metabolism
and intermediates formation (e.g. glutathione conjugates). The bio-
transformation process is an important issue for understanding the
efficiency, mode of action and potential toxicity of ITCs as chemo-
preventive agents (Conaway et al., 2002).In the current study, we demonstrated with immunoblot that
all the 40 lM ITCs were able to activate Nrf2 after just 1 h of treat-
ment, though to different degrees, and thus leading to its partial
translocation into the nucleus. Of course the differences observed
in Nrf2 activation in the rat hepatocytes, could be due to a different
time dependence with a consequent impact on the expression of
Nrf2-target genes as found in hepatoma HepG2 cells (Jeong et al.,
2005). However, it should be noted that other mechanisms not
mentioned here might be involved in the regulation of the antiox-
idant and phase II genes, especially in the liver, in addition to the
ARE/Nrf2-mediated pathway.
In conclusion, this study has established for the first time in pri-
mary rat hepatocytes that ITCs with various chemical structures
are able to modulate, although in different ways, CYPs, antioxidant
and phase II enzymes and activate Nrf2. This data supports the sug-
gestion put forward by Keum et al. (2008) that ITCs, as a class of
electrophilic compounds, are general activators of ARE/Nrf2 regu-
lated genes.Conflict of Interest
The authors declare that there are no conflicts of interest.
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